Research and Development

Welcome to our Research Unit

Phase I/II trials

At the heart of our outpatient/ inpatient medical facility, we have established a Research Unit which offers the ideal platform for pharmaceutical companies seeking to conduct Phase I/II trials.  .

What makes our unit special?

• On site Internal Review Board approved by the local regulators which can meet upon demand, thus avoiding regulatory related delays.
• Located at the edge of the largest medical center in the country with easy access to sophisticated laboratories and imaging facilities as well as fully equipped ER.
• GCP trained staff and familiarity with the expectation of MOH and FDA.
• Medical leadership with vast experience in hundreds of trials supported by the pharmaceutical industry and/or academic grants.
• Customized Service: Personalized approach tailored to the specific requirements of each project and company.
• Digital tools that allow a quick patient’s recruitment of healthy volunteers.

Defining Objectives and Risks:

We begin each research project with a clear definition of objectives and risks, carefully balancing the potential benefits with participant safety considerations.

Data Collection and Analysis:

We are committed to accurate and reliable data collection, using advanced technologies for analyzing results, ensuring that our findings are trustworthy and relevant.

Commitment to Innovation and Ethics

Our institution is committed to full transparency, compliance with all regulatory requirements, and the advancement of the best possible care for patients. We believe that the combination of scientific expertise and adherence to GCP principles is the foundation for developing revolutionary and safe treatments.

Come to visit us!

You can schedule an appointment for a tour of our        new unit and see up close our dedicated staff and      equipment.

Contact Us Now for More Details:

Email: Helsinki-rg@alzheimer.org.il